Clinical Perspectives of Gut Microbiota in Patients with Chronic Kidney Disease and End-Stage Kidney Disease: Where Do We Stand?
- PMID: 37760920
- PMCID: PMC10525496
- DOI: 10.3390/biomedicines11092480
Clinical Perspectives of Gut Microbiota in Patients with Chronic Kidney Disease and End-Stage Kidney Disease: Where Do We Stand?
Abstract
The gut microbiota (GM) plays a vital role in human health, with increasing evidence linking its imbalance to chronic kidney disease and end-stage kidney disease. Although the exact methods underlying kidney-GM crosstalk are not fully understood, interventions targeting GM were made and lay in three aspects: diagnostic, predictive, and therapeutic interventions. While these interventions show promising results in reducing uremic toxins and inflammation, challenges remain in the form of patient-specific GM variability, potential side effects, and safety concerns. Our understanding of GMs role in kidney disease is still evolving, necessitating further research to elucidate the causal relationship and mechanistic interactions. Personalized interventions focusing on specific GM signatures could enhance patient outcomes. However, comprehensive clinical trials are needed to validate these approaches' safety, efficacy, and feasibility.
Keywords: dysbiosis; gut microbiota; kidney disease; probiotic; uremic toxin.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
[Pathomechanism and treatment of gut microbiota dysbiosis in chronic kidney disease and interventional effects of Chinese herbal medicine].Zhongguo Zhong Yao Za Zhi. 2017 Jul;42(13):2425-2432. doi: 10.19540/j.cnki.cjcmm.20170609.014. Zhongguo Zhong Yao Za Zhi. 2017. PMID: 28840678 Review. Chinese.
-
The Impact of CKD on Uremic Toxins and Gut Microbiota.Toxins (Basel). 2021 Mar 31;13(4):252. doi: 10.3390/toxins13040252. Toxins (Basel). 2021. PMID: 33807343 Free PMC article. Review.
-
Gut microbiota and inflammation in chronic kidney disease patients.Clin Kidney J. 2015 Jun;8(3):332-4. doi: 10.1093/ckj/sfv026. Epub 2015 May 6. Clin Kidney J. 2015. PMID: 26034597 Free PMC article.
-
The Potential Benefits and Controversies of Probiotics Use in Patients at Different Stages of Chronic Kidney Disease.Nutrients. 2022 Sep 29;14(19):4044. doi: 10.3390/nu14194044. Nutrients. 2022. PMID: 36235699 Free PMC article. Review.
-
Microbiota-derived uremic retention solutes: perpetrators of altered nonrenal drug clearance in kidney disease.Expert Rev Clin Pharmacol. 2018 Jan;11(1):71-82. doi: 10.1080/17512433.2018.1378095. Epub 2017 Sep 20. Expert Rev Clin Pharmacol. 2018. PMID: 28905671 Free PMC article. Review.
Cited by
-
Challenging directions in pediatric diabetes - the place of oxidative stress and antioxidants in systemic decline.Front Pharmacol. 2024 Dec 18;15:1472670. doi: 10.3389/fphar.2024.1472670. eCollection 2024. Front Pharmacol. 2024. PMID: 39744134 Free PMC article. Review.
-
Oral Cardiac Drug-Gut Microbiota Interaction in Chronic Heart Failure Patients: An Emerging Association.Int J Mol Sci. 2024 Jan 31;25(3):1716. doi: 10.3390/ijms25031716. Int J Mol Sci. 2024. PMID: 38338995 Free PMC article. Review.
-
Unraveling Intestinal Microbial Shifts in ESRD and Kidney Transplantation: Implications for Disease-Related Dysbiosis.Microorganisms. 2023 Nov 10;11(11):2747. doi: 10.3390/microorganisms11112747. Microorganisms. 2023. PMID: 38004758 Free PMC article.
-
Gut microbiome remodeling in chronic kidney disease: implications of kidney replacement therapies and therapeutic interventions.Front Med (Lausanne). 2025 Jul 15;12:1620247. doi: 10.3389/fmed.2025.1620247. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40735439 Free PMC article. Review.
-
The role of vitamin D in pediatric systemic lupus erythematosus - a double pawn in the immune and microbial balance.Front Immunol. 2024 Apr 23;15:1373904. doi: 10.3389/fimmu.2024.1373904. eCollection 2024. Front Immunol. 2024. PMID: 38715605 Free PMC article. Review.
References
-
- Nori W., Akram N.N., Mueen Al-kaabi M. Probiotics in Women and Pediatrics Health; A Narrative Review. Al-Anbar Med. J. 2023;19:10–16. doi: 10.33091/amj.2023.138442.1021. - DOI
Publication types
LinkOut - more resources
Full Text Sources